Emilia Jaskuła

486 total citations
27 papers, 285 citations indexed

About

Emilia Jaskuła is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, Emilia Jaskuła has authored 27 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Hematology and 8 papers in Epidemiology. Recurrent topics in Emilia Jaskuła's work include Immune Cell Function and Interaction (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Emilia Jaskuła is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Emilia Jaskuła collaborates with scholars based in Poland, Pakistan and Germany. Emilia Jaskuła's co-authors include Andrzej Lange, Katarzyna Bogunia‐Kubik, Dorota Dłubek, Dorota Duda, Grzegorz Mazur, Kazimierz Kuliczkowski, Ilona Kryczek, Aleksandra Butrym, Tomasz Wróbel and Jerzy Liebhart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Emilia Jaskuła

26 papers receiving 284 citations

Peers

Countries citing papers authored by Emilia Jaskuła

Since Specialization

Citations

This map shows the geographic impact of Emilia Jaskuła's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilia Jaskuła with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilia Jaskuła more than expected).

Fields of papers citing papers by Emilia Jaskuła

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilia Jaskuła. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilia Jaskuła. The network helps show where Emilia Jaskuła may publish in the future.

Co-authorship network of co-authors of Emilia Jaskuła

This figure shows the co-authorship network connecting the top 25 collaborators of Emilia Jaskuła. A scholar is included among the top collaborators of Emilia Jaskuła based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilia Jaskuła. Emilia Jaskuła is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies 2024 ·Biomarker Research ·(unknown), Monika Jasek, Lidia Karabon, Emilia Jaskuła	2
2	Influence of vascular endothelial growth factoron neutrophil activation in asthmatics 2022 ·Advances in Dermatology and Allergology ·Krzysztof Gomułka, Jerzy Liebhart, Emilia Jaskuła, W Medrala	2
3	CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications 2021 ·Transplant Immunology ·Emilia Jaskuła, (unknown), (unknown), Krzysztof Suchnicki, (unknown), (unknown), Andrzej Lange	1
4	Peripheral blood eosinophils priming and in vitro VEGF stimulation in asthmatics 2021 ·Advances in Dermatology and Allergology ·Krzysztof Gomułka, Jerzy Liebhart, Emilia Jaskuła, W Medrala	3
5	Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients 2021 ·Frontiers in Immunology ·Andrzej Lange, (unknown), Emilia Jaskuła	18
6	Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak 2020 ·Polskie Archiwum Medycyny Wewnętrznej ·Emilia Jaskuła, Andrzej Lange	2
7	The –2549 –2567 del18 Polymorphism in VEGF and Irreversible Bronchoconstriction in Asthmatics 2018 ·Journal of Investigational Allergology and Clinical Immunology ·Krzysztof Gomułka, Jerzy Liebhart, Emilia Jaskuła, Andrzej Lange, W Medrala	10
8	High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas 2018 ·Current Problems in Cancer ·Aleksandra Butrym, Ilona Kryczek, Dorota Dłubek, Emilia Jaskuła, Andrzej Lange, Artur Jurczyszyn, Grzegorz Mazur	4
9	The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow 2018 ·PLoS ONE ·Andrzej Lange, Emilia Jaskuła, (unknown), Grzegorz Dworacki, Dorota Nowak, Aleksandra Simiczyjew, (unknown), (unknown)	15
10	Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease 2017 ·Blood ·Emilia Jaskuła, Andrzej Lange, (unknown), Jakub Chrustowicz, (unknown), (unknown)	1
11	Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results 2016 ·Archivum Immunologiae et Therapiae Experimentalis ·(unknown), (unknown), Katarzyna Bogunia‐Kubik, Barbara Wysoczańska, Emilia Jaskuła, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrzej Lange, Jacek Nowak	8
12	Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse 2014 ·Journal of Immunotoxicology ·Andrzej Lange, Dorota Dłubek, (unknown), (unknown), (unknown), Aleksandra Klimczak, (unknown), Emilia Jaskuła	3
13	Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor 2014 ·PLoS ONE ·Grzegorz Mazur, Aleksandra Butrym, Ilona Kryczek, Dorota Dłubek, Emilia Jaskuła, Andrzej Lange, Kazimierz Kuliczkowski, Michał Jeleń	17
14	NOD2/CARD15 Single Nucleotide Polymorphism 13 (3020insC) is Associated with Risk of Sepsis and Single Nucleotide Polymorphism 8 (2104C>T) with Herpes Viruses Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation 2013 ·Biology of Blood and Marrow Transplantation ·Emilia Jaskuła, Andrzej Lange, Sławomira Kyrcz‐Krzemień, Mirosław Markiewicz, Monika Dzierżak‐Mietła, W Wiktor-Jędrzejczak, (unknown), (unknown), (unknown), (unknown), Jacek Nowak, Krzysztof Warzocha, Andrzej Hellmann, Jerzy Kowalczyk, Katarzyna Drabko, (unknown), (unknown)	16
15	Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma 2011 ·SHILAP Revista de lepidopterología ·Grzegorz Mazur, Emilia Jaskuła, Ilona Kryczek, Dorota Dłubek, Aleksandra Butrym, Tomasz Wróbel, Andrzej Lange, Kazimierz Kuliczkowski	2
16	Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma 2011 ·Folia Histochemica et Cytobiologica ·Grzegorz Mazur, Emilia Jaskuła, Ilona Kryczek, Dorota Dłubek, Aleksandra Butrym, Tomasz Wróbel, Andrzej Lange, Kazimierz Kuliczkowski	19
17	Reactivations of Cytomegalovirus, Human Herpes Virus 6, and Epstein-Barr Virus Differ with Respect to Risk Factors and Clinical Outcome after Hematopoietic Stem Cell Transplantation 2010 ·Transplantation Proceedings ·Emilia Jaskuła, Dorota Dłubek, (unknown), Dorota Duda, (unknown), Andrzej Lange	39
18	Association With the Presence of Naive T Cells in Chronic Myeloid Leukemia Patients After Allogeneic Human Stem Cell Transplantation and the Lower Incidence of Chronic Graft-Versus Host Disease and Relapse 2007 ·Transplantation Proceedings ·Barbara Wysoczańska, Katarzyna Bogunia‐Kubik, Dorota Dłubek, Emilia Jaskuła, (unknown), (unknown), (unknown), Andrzej Lange	6
19	The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation 2007 ·Bone Marrow Transplantation ·Katarzyna Bogunia‐Kubik, Emilia Jaskuła, Andrzej Lange	19
20	The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation 2005 ·British Journal of Haematology ·Katarzyna Bogunia‐Kubik, (unknown), Emilia Jaskuła, Andrzej Lange	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact